|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,078.00 JPY | -1.38% |
|
-3.75% | +56.25% |
| Dec. 09 | Lukoil's international assets and potential buyers | RE |
| Dec. 08 | Kazakhstan to supply some Kashagan oil to China directly due to CPC damage, sources say | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.27 | 7.54 | 13.64 | 11.61 | 10.32 | |||||
Return on Total Capital | 3.59 | 8.43 | 15.84 | 13.89 | 12.39 | |||||
Return On Equity % | -3.3 | 6.74 | 11.97 | 7.79 | 9.01 | |||||
Return on Common Equity | -3.87 | 7.61 | 12.7 | 8.06 | 9.46 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.95 | 54.28 | 59.42 | 60.82 | 59.6 | |||||
SG&A Margin | 7.4 | 4.68 | 4.13 | 4.55 | 5.82 | |||||
EBITDA Margin % | 55.68 | 64.35 | 66.59 | 70.55 | 67.3 | |||||
EBITA Margin % | 33.1 | 48.02 | 54 | 55.79 | 51.45 | |||||
EBIT Margin % | 32.23 | 47.47 | 53.62 | 55.79 | 51.45 | |||||
Income From Continuing Operations Margin % | -13.46 | 17.19 | 19.01 | 15.36 | 19.16 | |||||
Net Income Margin % | -14.49 | 17.92 | 18.85 | 14.86 | 18.86 | |||||
Net Avail. For Common Margin % | -14.49 | 17.92 | 18.85 | 14.86 | 18.86 | |||||
Normalized Net Income Margin | 20.37 | 34.06 | 40.81 | 35.24 | 35.89 | |||||
Levered Free Cash Flow Margin | 20.33 | 33.02 | 39.57 | 25.05 | 29.41 | |||||
Unlevered Free Cash Flow Margin | 21.87 | 33.71 | 40.44 | 27.19 | 31.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.16 | 0.25 | 0.41 | 0.33 | 0.32 | |||||
Fixed Assets Turnover | 0.35 | 0.57 | 0.98 | 0.71 | 0.6 | |||||
Receivables Turnover (Average Receivables) | 7.46 | 10.93 | 11.74 | 9.17 | 9.07 | |||||
Inventory Turnover (Average Inventory) | 12 | 13.86 | 16.27 | 12.29 | 13.35 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.14 | 1.49 | 1.38 | 1.47 | 1.63 | |||||
Quick Ratio | 0.87 | 1.15 | 1.12 | 0.78 | 0.97 | |||||
Operating Cash Flow to Current Liabilities | 0.86 | 1.28 | 1.43 | 1.38 | 1.23 | |||||
Days Sales Outstanding (Average Receivables) | 49.03 | 33.4 | 31.09 | 39.79 | 40.34 | |||||
Days Outstanding Inventory (Average Inventory) | 30.49 | 26.34 | 22.43 | 29.7 | 27.41 | |||||
Average Days Payable Outstanding | 15.51 | 9.39 | 11.75 | 54.78 | 80.3 | |||||
Cash Conversion Cycle (Average Days) | 64.01 | 50.34 | 41.77 | 14.71 | -12.55 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 41.14 | 35.27 | 31.45 | 23.49 | 20.71 | |||||
Total Debt / Total Capital | 29.15 | 26.07 | 23.93 | 19.02 | 17.16 | |||||
LT Debt/Equity | 35.31 | 32.86 | 29.58 | 19.91 | 16.93 | |||||
Long-Term Debt / Total Capital | 25.02 | 24.29 | 22.5 | 16.13 | 14.03 | |||||
Total Liabilities / Total Assets | 35.24 | 35.12 | 35.51 | 33.24 | 30.39 | |||||
EBIT / Interest Expense | 13.01 | 42.97 | 38.5 | 16.28 | 12.6 | |||||
EBITDA / Interest Expense | 22.49 | 58.25 | 47.81 | 20.59 | 16.48 | |||||
(EBITDA - Capex) / Interest Expense | 15.69 | 48.03 | 42.03 | 17.19 | 13.23 | |||||
Total Debt / EBITDA | 2.88 | 1.47 | 0.82 | 0.69 | 0.7 | |||||
Net Debt / EBITDA | 2.45 | 1.22 | 0.64 | 0.56 | 0.54 | |||||
Total Debt / (EBITDA - Capex) | 4.12 | 1.79 | 0.93 | 0.83 | 0.87 | |||||
Net Debt / (EBITDA - Capex) | 3.51 | 1.48 | 0.72 | 0.67 | 0.67 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -39.33 | 61.39 | 86.81 | -6.89 | 4.68 | |||||
Gross Profit, 1 Yr. Growth % | -54.25 | 103.94 | 104.49 | -4.69 | 2.59 | |||||
EBITDA, 1 Yr. Growth % | -46.89 | 86.5 | 93.32 | -1.35 | -0.14 | |||||
EBITA, 1 Yr. Growth % | -59.83 | 134.11 | 110.1 | -3.81 | -3.46 | |||||
EBIT, 1 Yr. Growth % | -60.47 | 137.72 | 111.02 | -3.12 | -3.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -169.35 | -306.08 | 106.57 | -24.74 | 30.57 | |||||
Net Income, 1 Yr. Growth % | -171.12 | -299.69 | 96.49 | -26.6 | 32.84 | |||||
Normalized Net Income, 1 Yr. Growth % | -62.08 | 169.91 | 123.82 | -19.6 | 6.61 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -171.12 | -301.14 | 108.42 | -22.55 | 38.93 | |||||
Accounts Receivable, 1 Yr. Growth % | -46.97 | 118.09 | 53.68 | -3.29 | 15.28 | |||||
Inventory, 1 Yr. Growth % | -12.02 | 39.41 | 42.53 | 2.5 | -3.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.04 | 9.18 | 9.44 | 46.66 | 7.09 | |||||
Total Assets, 1 Yr. Growth % | -4.44 | 11.3 | 21.4 | 7.62 | 9.52 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.41 | 16.68 | 23.03 | 26.88 | 14.47 | |||||
Common Equity, 1 Yr. Growth % | -10.01 | 14.16 | 20.9 | 11.44 | 14.56 | |||||
Cash From Operations, 1 Yr. Growth % | -22.53 | 52.08 | 68.65 | 4.9 | -16.93 | |||||
Capital Expenditures, 1 Yr. Growth % | -17.39 | 8.27 | 33.2 | 34.76 | 19.41 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | - | 162.17 | 123.85 | -41.05 | 22.89 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | - | 148.72 | 124.08 | -37.38 | 23.03 | |||||
Dividend Per Share, 1 Yr. Growth % | -38.46 | 100 | 29.17 | 19.35 | 16.22 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | - | -1.05 | 73.64 | 31.89 | -1.27 | |||||
Gross Profit, 2 Yr. CAGR % | - | -3.4 | 104.22 | 39.61 | -1.12 | |||||
EBITDA, 2 Yr. CAGR % | - | -0.48 | 89.88 | 38.1 | -0.74 | |||||
EBITA, 2 Yr. CAGR % | - | -3.02 | 121.78 | 42.16 | -3.64 | |||||
EBIT, 2 Yr. CAGR % | - | -3.07 | 123.97 | 42.98 | -3.29 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 19.55 | 106.32 | 24.68 | -0.87 | |||||
Net Income, 2 Yr. CAGR % | - | 19.17 | 98.08 | 20.1 | -1.26 | |||||
Normalized Net Income, 2 Yr. CAGR % | - | 1.17 | 145.79 | 34.14 | -7.42 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 19.61 | 104.75 | 27.05 | 3.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | 7.54 | 83.07 | 21.91 | 5.59 | |||||
Inventory, 2 Yr. CAGR % | - | 10.75 | 40.96 | 20.87 | -0.67 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | - | -0.34 | 9.31 | 26.69 | 25.32 | |||||
Total Assets, 2 Yr. CAGR % | - | 3.13 | 16.24 | 14.3 | 8.56 | |||||
Tangible Book Value, 2 Yr. CAGR % | - | 3.37 | 19.81 | 24.94 | 20.51 | |||||
Common Equity, 2 Yr. CAGR % | - | 1.36 | 17.48 | 16.07 | 12.99 | |||||
Cash From Operations, 2 Yr. CAGR % | - | 8.54 | 60.15 | 33.01 | -6.65 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | -5.43 | 20.09 | 33.98 | 26.85 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | 142.25 | 14.88 | -14.89 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | 136.08 | 18.45 | -12.23 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 10.94 | 60.73 | 24.16 | 17.78 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | - | - | 22.3 | 41.07 | 22.11 | |||||
Gross Profit, 3 Yr. CAGR % | - | - | 24.03 | 58.41 | 25.98 | |||||
EBITDA, 3 Yr. CAGR % | - | - | 24.18 | 52.65 | 23.95 | |||||
EBITA, 3 Yr. CAGR % | - | - | 25.48 | 67.87 | 24.95 | |||||
EBIT, 3 Yr. CAGR % | - | - | 25.63 | 69.38 | 25.44 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | 43.46 | 47.42 | 26.62 | |||||
Net Income, 3 Yr. CAGR % | - | - | 40.79 | 42.28 | 24.2 | |||||
Normalized Net Income, 3 Yr. CAGR % | - | - | 31.82 | 69.35 | 24.25 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 43.93 | 48.08 | 30.89 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | 21.13 | 47.99 | 19.66 | |||||
Inventory, 3 Yr. CAGR % | - | - | 20.46 | 26.76 | 12.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | 2.82 | 20.56 | 19.79 | |||||
Total Assets, 3 Yr. CAGR % | - | - | 8.89 | 13.29 | 12.69 | |||||
Tangible Book Value, 3 Yr. CAGR % | - | - | 9.55 | 22.12 | 21.35 | |||||
Common Equity, 3 Yr. CAGR % | - | - | 7.49 | 15.43 | 15.57 | |||||
Cash From Operations, 3 Yr. CAGR % | - | - | 25.72 | 39.09 | 13.7 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | - | 6.01 | 24.79 | 28.93 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 51.24 | 17.49 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 51.68 | 19.96 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 16.71 | 45.55 | 21.46 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 12.26 | |||||
Gross Profit, 5 Yr. CAGR % | - | - | - | - | 13.28 | |||||
EBITDA, 5 Yr. CAGR % | - | - | - | - | 13.53 | |||||
EBITA, 5 Yr. CAGR % | - | - | - | - | 12.91 | |||||
EBIT, 5 Yr. CAGR % | - | - | - | - | 13.15 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | 23.74 | |||||
Net Income, 5 Yr. CAGR % | - | - | - | - | 22.16 | |||||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | 14.45 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | 26.26 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 14.65 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | 11.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | 11.29 | |||||
Total Assets, 5 Yr. CAGR % | - | - | - | - | 8.76 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | 13.81 | |||||
Common Equity, 5 Yr. CAGR % | - | - | - | - | 9.66 | |||||
Cash From Operations, 5 Yr. CAGR % | - | - | - | - | 11.61 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | - | 13.9 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | - | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | - | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | 17.14 |
- Stock Market
- Equities
- 1605 Stock
- Financials Inpex Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















